AB0313 Cardiovascular Risk, Biologics and Anti-Cyclic Citrullinated Peptide Positivity in Rheumatoid Arthritis
doi 10.1136/annrheumdis-2017-eular.6465
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism